Charles Bruce Kemmler, MD, PhD
Emergency Medicine
Accepting new patients
Sees patients age 18 and up
Penn Emergency Medicine Penn Presbyterian
Penn Medicine Provider
About me
- Assistant Professor of Clinical Emergency Medicine
My education and training
- Medical School: University of Colorado at Denver
- Residency: University of Pennsylvania Health System
Spoken languages
English
English
Insurance accepted
Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.
- Aetna Advantra Cares D-SNP
- Aetna Advantra Credit Value
- Aetna Advantra Eagle HMO
- Aetna Advantra Eagle POS
- Aetna Advantra Premier Plus PPO
- Aetna Advantra Value
- Aetna Advantra Value Plus
- Aetna APCN Plus (Multi-Tier)
- Aetna Better Health Kids (CHIP) - DH Only
- Aetna Flexible Five
- Aetna Freedom Core
- Aetna Gold
- Aetna HMO
- Aetna Philly Prime
- Aetna POS
- Aetna PPO APCN
- Aetna Premier
- Aetna Premier Plus
- Aetna Savings Plus
- Aetna Signature Administrators
- Aetna Student Health Plan PPO
- Aetna Upfront Advantage
- First Health HMO
- First Health POS
- First Health PPO
- Meritain - Aramark (Other)
- Meritain - Aramark (Pennsylvania Premier Medical Plan)
- Americhealth Caritas of PA VIP - LGH Only
- Amerihealth Caritas (Transplant patients only)
- Amerihealth Caritas of PA - LGH Only
- Centivo EPO
- Cigna Healthcare EPO
- Cigna Healthcare HMO
- Cigna Healthcare POS
- Cigna Healthcare PPO
- Claim Watcher (Homestead/ INDECs) Open Access
- Clover Health Choice
- Clover Health Choice Value PPO
- Clover Health Classic HMO
- Clover Health Value
Locations
Penn Medicine hospital privileges
- Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
- Pennsylvania Hospital: Has privileges to treat patients in the hospital.
- Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Qualifications and experience
- Emergency Medicine, 2021
- American Academy of Emergency Medicine, National
- American College of Emergency Physicians, National
- Society for Academic Emergency Medicine, National
Treatments and conditions
Research
Publications
Jackson, E.M. and C.B. Kemmler Young Man with Right Flank and Leg Swelling , Annals of Emergency Medicine, 83(5): 2024,490-491
Kemmler CB, Sangal RB, Rothenberg C, Li SX, Shofer FS, Abella BS, Venkatesh AK, Foster SD Delays in antibiotic redosing: Association with inpatient mortality and risk factors for delay , Am J Emerg Med. , 46: 2021,63-69
Kemmler C.B., Saleem, S.G., Ali, S., Samad, L., Haider, K.F., Jamal, M.I., Aziz, T., Maroof, Q., Dadabhoy, F.Z., Yasin, Z., Rybarczyk, M.M. A 1-year training program in emergency medicine for physicians in Karachi, Pakistan: Evaluation of learner and program outcomes , AEM Educ Train, 5(3): 2021,e10625
King TH, Kemmler CB, Guo Z, Mann D, Lu Y, Coeshott C, Gehring AJ, Bertoletti A, Ho ZZ, Delaney W, Gaggar A, Subramanian GM, McHutchison JG, Shrivastava S, Lee YJ, Kottilil S, Bellgrau D, Rodell T and D. Apelian A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and Core specific T cells in mice and activates human T cells recognizing epitopes linked to viral clearance , PLoS One, 9(7): 2014,e101904
Buhrman JD, Jordan KR, U’Ren L, Sprague J, Kemmler CB, and Slansky JE Augmenting antitumor T-cell responses to mimotope vaccination by boosting with native tumor antigens , Cancer Research, 73(1): 2013,74-85
Kemmler CB, Clambey ET, Kedl RM, Slansky JE Elevated tumor-association antigen expression suppresses variant peptide vaccine responses , J. Immunol, 187(9): 2011,4431-9
Jordan KR, McMahan RH, Kemmler CB, Kappler JW, Slansky JE Peptide vaccines prevent tumor growth by activating T cells that respond to native tumor antigens , Natl. Acad. Sci., 107(10): 2010,4652-7
McWilliams JA, Sullivan RT, Jordan KR, McMahan RH, Kemmler CB, McDuffie M, Slansky JE Age-dependent tolerance to an endogenous tumor-associated antigen , Vaccine, 26: 2008,1863-73
Haller AA, Lauer GM, King TH, Kemmler CB, Fiolkoski V, Lu Y, Bellgrau D, Rodell, TC, Apelian D, Franzusoff A, Duke RC Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins , Vaccine, 25(8): 2007,1452-63